When one person died and four others were seriously harmed in a French drug test, Portugal-based drug maker Bial initially adopted the distancing tool known to all good writers: the passive voice. In a new Wall Street Journal “Risk and Compliance” post, she comments on what Bial did, didn’t, and should be doing.
Judy Phair Looks at Drug Manufacturer’s Handling of Drug Test Gone Awry
March 29, 2016 By Leave a Comment
Speak Your Mind